首页|意象对话疗法治疗代谢相关脂肪性肝病疗效观察

意象对话疗法治疗代谢相关脂肪性肝病疗效观察

扫码查看
目的 研究探讨意象对话疗法在代谢相关脂肪性肝病治疗中的效果.方法 选取2021年3月至2024年3月广东省佛山市第一人民医院60例代谢相关脂肪性肝病患者,按照随机数字表法分为观察组和对照组,各30例.对照组给予常规健康教育,观察组在对照组基础上加意向对话疗法干预.3个月后评估2组患者的肝功能指标、血脂指标、负性情绪评分、遵医行为率.结果 治疗后,观察组肝功能各项指标水平均低于对照组(P<0.05),各项血脂指标水平优于对照组(P<0.05),观察组负性情绪评分均低于对照组(P<0.05).观察组遵医行为率高于对照组(P<0.05).结论 意象对话疗法在代谢相关脂肪性肝病中应用良好,能改善患者的肝功能、血脂指标,缓解患者的负性情绪,提高患者的遵医行为率.
Observation on the Therapeutic Effect of Imagery Dialogue Therapy in the Treatment of Metabolic-Associated Fatty Liver Diseas
Objective To investigate the application and therapeutic effect of imagery dialogue therapy in the treatment of non-alcoholic fatty liver disease ( NAFLD ) .Methods Sixty patients with NAFLD were divided into an observation group and a control group,with 30 patients in each.The control group received routine health education,while the observation group underwent imagery dialogue therapy interventions in addition to routine treatment.After 3 months,the study evaluated liver function indicators,lipid metabolism indicators,negative emotion scores ( using HAMA and HAMD scales ),and compliance rates for regular diet,daily routine,medication adherence,rehabilitation training,and follow-up examinations in both groups.Results The liver function indicators in the observation group were significantly lower than those in the control group ( P<0.05 ) .The blood lipid levels in the observation group were also significantly better ( or "more favorable" ) than those in the control group ( P<0.05 ) .The negative emotion scores ( HAMA and HAMD ) in the observation group were significantly lower than those in the control group ( P<0.05 ) .Furthermore,the compliance rates for regular diet,daily routine,medication adherence,rehabilitation training,and follow-up examinations were significantly higher in the observation group compared to the control gr oup ( P<0.05 ) .Conclusion The results indicate that imagery dialogue therapy effectively treats NAFLD by improving liver function and lipid metabolism,alleviating negative emotions,and enhancing patient compliance rates.

Metabolic-Associated Fatty Liver DiseaseImagery Dialogue TherapyLiver Function IndicatorsAnxietyDepressionComparative Study on Therapeutic Efficacy

朱茜、张虹桥、丘志琼、周峰

展开 >

528000 广东 佛山,广东省佛山市第一人民医院心理科

代谢相关脂肪性肝病 意向对话疗法 肝功能指标 焦虑 抑郁 疗效比较研究

2024

转化医学杂志
海军总医院

转化医学杂志

CSTPCD
影响因子:0.671
ISSN:2095-3097
年,卷(期):2024.13(3)